William Harris, PhD, a researcher with Sanford Research/USD, was published today in the Journal of the American Medical Association (JAMA). This is the second time in three months JAMA published Dr. Harris' research.
(Sioux Falls, SD) - Cardiovascular research at Sanford continues to attract national recognition. William Harris, PhD, a researcher with Sanford Research/USD, was published today in the Journal of the American Medical Association (JAMA). This is the second time in three months JAMA published Dr. Harris’ research.
Dr. Harris serves as the Director of the Cardiovascular Health Research Center at Sanford Research/USD in Sioux Falls, SD and is a Research Professor of Medicine at the Sanford School of Medicine at The University of South Dakota. He is an internationally recognized expert on how omega-3 fatty acids can benefit patients with heart disease.
In this latest paper, published January 20, 2010, Dr. Harris provided the omega-3 analyses for the study. The paper, Association of marine omega-3 fatty acid levels with telomeric aging in patients with coronary heart disease, determined that higher omega-3 levels were associated with slower cellular aging.
In the October 21, 2009 issue of JAMA, Dr. Harris was part of the team that published the paper entitled Omega-3 Augmentation of Sertraline in Treatment of Depression in Patients With Coronary Heart Disease.
“With our latest discovery that higher blood levels of omega-3 fatty acids are associated with slowed ‘cellular aging’ we are opening a new chapter in the story of how fish oils improve human health,” says Dr. Harris. “Future studies are now needed to see if fish oil supplementation per se will slow the aging process.”
“Our vision is to truly improve the human condition,” said David Link, Executive Vice President Sanford Health-MeritCare. “Dr. Harris and the impressive team of researchers assembled at Sanford continually provide significant contributions to improve the health and wellness of people everywhere.”
» JAMA PAPER - Association of marine omega-3 fatty acid levels with telomeric aging in patients with coronary heart disease.
About Sanford Research/USD
In 1998, a non-profit research organization was formed between Sanford Health and the University of South Dakota. In 2007, a transformational gift of $400 million by Denny Sanford has allowed for an expansion of current research goals and will enable Sanford Research/USD to become one of the premiere research institutions in the United States and the world. Over the years, Sanford Research/USD has made significant contributions to the research areas of cardiovascular health, women’s health, cancer biology, disparities, pediatrics, metabolism/nutrition and genomics.
For more information, visit www.sanfordhealth.org/research.
Stacy Bauer Jones | Media Relations Coordinator
(605) 328-7056 | email@example.com